BL-918

activator of UNC-51-like kinase 1 (ULK1)

Also Known As:

(2R)-2-((3,5-bis(trifluoromethyl)phenyl)carbamothioylamino)-N-(2,4-difluorophenyl)-2-phenylacetamide; BL918

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Parkinson Disease (Parkinson's Disease) 03/01/2023 - "We previously identified that BL-918 as a specific ULK1 activator, which exerted cytoprotective effect against Parkinson's disease in vitro and in vivo. "
2.	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/01/2023 - "BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy."

1.	Therapeutics